OGN
Price
$10.38
Change
+$0.70 (+7.23%)
Updated
Sep 5 closing price
Capitalization
2.7B
54 days until earnings call
SNY
Price
$46.50
Change
+$1.17 (+2.58%)
Updated
Sep 5 closing price
Capitalization
112.23B
48 days until earnings call
Interact to see
Advertisement

OGN vs SNY

Header iconOGN vs SNY Comparison
Open Charts OGN vs SNYBanner chart's image
Organon & Co
Price$10.38
Change+$0.70 (+7.23%)
Volume$4.65M
Capitalization2.7B
Sanofi ADS
Price$46.50
Change+$1.17 (+2.58%)
Volume$7.26M
Capitalization112.23B
OGN vs SNY Comparison Chart in %
Loading...
OGN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SNY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
OGN vs. SNY commentary
Sep 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is OGN is a StrongBuy and SNY is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 06, 2025
Stock price -- (OGN: $10.38 vs. SNY: $46.50)
Brand notoriety: OGN and SNY are both not notable
Both companies represent the Pharmaceuticals: Major industry
Current volume relative to the 65-day Moving Average: OGN: 112% vs. SNY: 289%
Market capitalization -- OGN: $2.7B vs. SNY: $112.23B
OGN [@Pharmaceuticals: Major] is valued at $2.7B. SNY’s [@Pharmaceuticals: Major] market capitalization is $112.23B. The market cap for tickers in the [@Pharmaceuticals: Major] industry ranges from $651.91B to $0. The average market capitalization across the [@Pharmaceuticals: Major] industry is $90.31B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

OGN’s FA Score shows that 2 FA rating(s) are green whileSNY’s FA Score has 1 green FA rating(s).

  • OGN’s FA Score: 2 green, 3 red.
  • SNY’s FA Score: 1 green, 4 red.
According to our system of comparison, OGN is a better buy in the long-term than SNY.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

OGN’s TA Score shows that 4 TA indicator(s) are bullish while SNY’s TA Score has 6 bullish TA indicator(s).

  • OGN’s TA Score: 4 bullish, 5 bearish.
  • SNY’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, SNY is a better buy in the short-term than OGN.

Price Growth

OGN (@Pharmaceuticals: Major) experienced а +10.19% price change this week, while SNY (@Pharmaceuticals: Major) price change was -6.02% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Major industry was +1.16%. For the same industry, the average monthly price growth was +3.94%, and the average quarterly price growth was +10.41%.

Reported Earning Dates

OGN is expected to report earnings on Oct 30, 2025.

SNY is expected to report earnings on Oct 24, 2025.

Industries' Descriptions

@Pharmaceuticals: Major (+1.16% weekly)

The Major Pharmaceuticals industry includes companies that are involved in various processes of creating drugs to treat/prevent diseases. These companies engage in research, testing and manufacturing, as well as the distribution of pharmaceuticals into markets. Johnson & Johnson, Merck & Co., Inc., Pfizer Inc. and Novartis are among the largest companies in this category.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
SNY($112B) has a higher market cap than OGN($2.7B). SNY has higher P/E ratio than OGN: SNY (15.49) vs OGN (3.86). SNY YTD gains are higher at: 0.686 vs. OGN (-28.834). SNY has higher annual earnings (EBITDA): 12.6B vs. OGN (1.5B). SNY has more cash in the bank: 15.4B vs. OGN (599M). OGN has less debt than SNY: OGN (8.9B) vs SNY (22.3B). SNY has higher revenues than OGN: SNY (45.7B) vs OGN (6.28B).
OGNSNYOGN / SNY
Capitalization2.7B112B2%
EBITDA1.5B12.6B12%
Gain YTD-28.8340.686-4,206%
P/E Ratio3.8615.4925%
Revenue6.28B45.7B14%
Total Cash599M15.4B4%
Total Debt8.9B22.3B40%
FUNDAMENTALS RATINGS
SNY: Fundamental Ratings
SNY
OUTLOOK RATING
1..100
16
VALUATION
overvalued / fair valued / undervalued
1..100
4
Undervalued
PROFIT vs RISK RATING
1..100
77
SMR RATING
1..100
61
PRICE GROWTH RATING
1..100
81
P/E GROWTH RATING
1..100
95
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
OGNSNY
RSI
ODDS (%)
Bearish Trend 2 days ago
59%
Bullish Trend 2 days ago
66%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
76%
Bullish Trend 2 days ago
45%
Momentum
ODDS (%)
Bullish Trend 2 days ago
69%
Bearish Trend 2 days ago
51%
MACD
ODDS (%)
Bullish Trend 2 days ago
70%
Bearish Trend 2 days ago
48%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
67%
Bearish Trend 2 days ago
50%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
63%
Bearish Trend 2 days ago
41%
Advances
ODDS (%)
Bullish Trend 11 days ago
67%
Bullish Trend 4 days ago
51%
Declines
ODDS (%)
Bearish Trend 19 days ago
73%
Bearish Trend 9 days ago
49%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
73%
Bullish Trend 2 days ago
58%
Aroon
ODDS (%)
N/A
Bullish Trend 2 days ago
56%
View a ticker or compare two or three
Interact to see
Advertisement
OGN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SNY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
CRYPTO / NAMEPrice $Chg $Chg %
HFT.X0.0992520.011117
+12.61%
Hashflow cryptocurrency
THETA.X0.7864440.024501
+3.22%
Theta Network cryptocurrency
GAL.X1.3803650.003258
+0.24%
Galatasaray Fan Token cryptocurrency
WAVES.X1.111981-0.001276
-0.11%
Waves cryptocurrency
ERN.X0.165716-0.016924
-9.27%
Ethos Reserve Note cryptocurrency

OGN and

Correlation & Price change

A.I.dvisor indicates that over the last year, OGN has been loosely correlated with PFE. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if OGN jumps, then PFE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To OGN
1D Price
Change %
OGN100%
+7.23%
PFE - OGN
46%
Loosely correlated
+1.39%
BIIB - OGN
40%
Loosely correlated
+0.52%
GSK - OGN
38%
Loosely correlated
+2.25%
JNJ - OGN
35%
Loosely correlated
-0.18%
LLY - OGN
35%
Loosely correlated
-2.11%
More

SNY and

Correlation & Price change

A.I.dvisor indicates that over the last year, SNY has been loosely correlated with GSK. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if SNY jumps, then GSK could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SNY
1D Price
Change %
SNY100%
+2.58%
GSK - SNY
51%
Loosely correlated
+2.25%
NVS - SNY
50%
Loosely correlated
+1.02%
PFE - SNY
49%
Loosely correlated
+1.39%
AZN - SNY
49%
Loosely correlated
-0.10%
MRK - SNY
43%
Loosely correlated
+0.79%
More